Bladder Cancer

Shaping your forecasting.

Welcome to theHub

Bladder Cancer

Bladder Cancer is cancer arising in the urinary bladder, generally from urothelial cells.

It is the fourth most common cancer in males and the ninth most common in females. While Bladder Cancer is associated with significant morbidity and mortality, prognosis tends to be good with 80-100% survival at 5 years. However, Bladder Cancer can also have high recurrence rates; therefore patients that have had bladder cancer require life-long monitoring. Main symptoms and co-morbidities for the disease include:

Smoking
Occupation
Bladder infections
Bladder stones
Family history

Treatments for bladder cancer include surgery, radiation therapy, chemotherapy, and biologic therapy. Biologic therapy boosts your body’s own ability to fight cancer.

Epidemiology Data

Data Available: Incidence Data

Data covers: Males and Females (where applicable) from 2010 to 2050.

Data is split into 5 year age ranges (0-4, 5-9 etc) from 0 to 100+ years, across multiple countries.

Additional sub filters of the data are available. Please see the below pop up box for more information.

Once purchased, the data will be provided in an embedded PowerBI document, in which the data can be filtered and viewed in a way which suits your needs. Raw data can also be downloaded. Below is an example embedded data set which can be filtered in a similar way.

Instructions:
Once the data set has been purchased, please refresh this page. The example data set will then be replaced with actual data.

Please contact us for further information regarding filtering of the data, viewing the data, data available, custom quotes, or anything else.

As well as incidence, data can be filtered by the following attributes :

• 1st line eligible and treated
• Anatomical Location
• Cachexia
• Histopathology
• Jewett-Strong Marshall Stage
• Lymph & Mets Distant Lymph
• Lymph & Mets Metastases
• Lymph & Mets No Lymph Involvement
• Lymph & Mets Regional Lymph
• Number of Primary Tumours
• PDL-1 Expression
• Smoking Status
• Tumour Stage Stage

Argentina
Australia
Austria
Belgium
Brazil
Canada
China
Czech Republic
Denmark
Finland
France
Germany
Hungary
India
Ireland
Italy
Japan
Mexico
Netherlands
Norway
Poland
Republic of Korea
Romania
Russian Federation
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Kingdom
United States of America

The more you buy, the more you save*

*discount added at checkout

For all your pharmaceutical
forecasting needs.

theHub is a portal of resources to help you create better forecasting. Courses, templates, software, data and working model examples to get you on the path to better forecasting. Sign up now to get access to a world of interactive content.

About J+D Forecasting.

At J+D it's our mission to simplify the complex nature of pharmaceutical forecasting to help support informed decision making for the future. We are dedicated to helping pharmaceutical and biotech companies use intelligent forecasting solutions to make strategic and operational investment decisions.

For decades, we have crafted bespoke pharmaceutical forecasting models, innovative software and interactive training solutions, each of which has been designed with client needs in mind, allowing businesses to create more intelligent and consistent insights.